Sun Pharma to conduct clinical trial in COVID-19 patients
Sun Pharmaceutical Industries Ltd said on Friday that it received Indian regulatory approval to start clinical trials of pancreatitis drug nafamostat mesilate in COVID-19 patients. | Read more|
